A novel formulation for the treatment of metastatic colorectal cancer, developed by University of Wollongong researchers, has been granted patent rights by the European Patent Office. The formulation, called Fluorodex, was developed to address key adverse events associated with current treatment regimens that are used to combat metastatic colorectal cancer. [ + ]

Gene therapy not only helps injured brain cells to live longer and regenerate, but also changes the shape of the cells, according to researchers at the University of Western Australia. [ + ]

Genetic Technologies' (ASX:GTG) Victorian lab has received US certification that will enable it to launch its BREVAGen cancer test in all 50 US states. [ + ]

A new genome map reveals the deadly facial tumour afflicting Tasmanian devils shows some unusual genetic properties. [ + ]

South Australia's Bionomics (ASX:BNO) is pursuing an international patent application for a method of improving memory in patients with Alzheimer's and other neurodegenerative diseases. [ + ]

Researchers have mapped the genome of the Tasmanian Devil for the first time, in a crucial step towards understanding the transmissible facial tumours decimating Devil populations and related human cancers. [ + ]

A research team, led by Dr Michel Bouvier at the Institute for Research in Immunology and Cancer (IRIC) of the University of Montreal in Quebec, has used the Roche xCELLigence SP Instrument to measure changes in cell response following ligand. [ + ]

Lorne Infection & Immunity: Resistance to antibiotics is an increasingly serious threat to human health worldwide. Now, a new Wellcome Trust-funded partnership with scientists in Queensland is fighting back. [ + ]

The biotech industry’s heavy hitters in business development are about to gather in Queensland for the annual dedicated forum for business development professionals. [ + ]

A trial of Phosphagenics' (ASX:POH) new TPM/oxycodone patch design proves that the redesign improves drug delivery by 4.5 times the original prototype version. [ + ]

The understanding of diseases such as Parkinson’s and Alzheimer’s is set to take a step forward following groundbreaking technology which will enable cell analysis using automated 3D microscopy. The technology will allow for the automated identification, separation and analysis of cells as complex as nerve cells in the brain. [ + ]

Former CEO of Avantogen, Dr William Ardrey, is to appear in Perth Magistrates Court this Friday on 19 counts of fraud. [ + ]

Australian scientists say they have made a genetic breakthrough which could help in the fight against cancer. The Melbourne-based team says it has pinpointed a link between non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin, and the ability of tumours to spread in the body. [ + ]

Stem cell scientists from the University of Queensland Centre for Clinical Research (UQCCR) have discovered a method for producing mesenchymal stem/stromal cells (MSCs) from human iPSCs that substantially improves on current methods and speeds up conversion time. [ + ]

Sydney-based Prima BioMed (ASX:PRR) has filed a registration for a dual-listing on the NASDAQ exchange, a move first announced in 2010. [ + ]